Fake diabetes, multivitamin medicines worth Rs 55 lakh for sale in Delhi, Haryana seized in Himachal Pradesh’s Baddi

Solan : Exposing yet another alleged laxity of the officers of the drug control department, a spurious drugs consignment having costing Rs 55 lakh was seized by a team of drug officials from a transport company vehicle and a pharmaceutical unit premises at Baddi on Sunday.

State Drugs Controller Navneet Marwaha confirmed that a transport godown of RS roadline located at Sai road in Baddi was raided where spurious drugs worth Rs 55 lakh of Sikkim-based Mankind and Intas Pharma pertaining to sugar and multivitamin tablets have been recovered. The said company did not have the license to manufacture these drugs and it had manufactured them in the name of the two companies.

Following this seizure, the manufacturing unit M/s Magnatek enterprise, where the drugs had been manufactured at Baddi was also raided and a huge stock of tablets and scrap were recovered by the team.

Raids were conducted throughout the night. The manufacturing premises of Magnatek enterprise have been sealed while the accused manufacture is absconding.

The vehicle of the transport company was seized in which medicines were being transported by the company. It was found that the firm had sold huge stock of spurious drugs in the market and department proceedings are under investigation to recover all material from the market informed Marwaha.

Drug controller Delhi has also been informed to seize the stock from a Central Delhi based wholesale trader whose bill was recovered from the transport company. The drugs were bound for Delhi and Haryana.

Involvement of other accused in the case is under investigation informed the officials.

Related Posts

After two years, pharma volumes pick up pace

NEW DELHI: The domestic pharmaceutical retail market is showing its strongest signs yet of a shift from price-led to demand-led growth. Volume growth crossed 3% in June, the first time…

NPPA fixes prices of 39 drugs, raises anti-rabies immunoglobulin rate

The National Pharmaceutical Pricing Authority (NPPA) has allowed an increase in the retail price of anti-rabies immunoglobulin while fixing the retail prices of 39 drug formulations.  According to a gazette…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

After two years, pharma volumes pick up pace

After two years, pharma volumes pick up pace

NPPA fixes prices of 39 drugs, raises anti-rabies immunoglobulin rate

NPPA fixes prices of 39 drugs, raises anti-rabies immunoglobulin rate

Tambaram police arrest two persons after seizing 1,100 banned tablets, 5 kg ganja

Tambaram police arrest two persons after seizing 1,100 banned tablets, 5 kg ganja

Rajasthan Healthcare Crisis: 8 Mothers Die Post-C-Section

Rajasthan Healthcare Crisis: 8 Mothers Die Post-C-Section

Steroid cream misuse fuels spurt in fungal infections

Steroid cream misuse fuels spurt in fungal infections

Dr Reddy’s delays semaglutide supplies due to API issue

Dr Reddy’s delays semaglutide supplies due to API issue